iCAD and Google Health Ink Strategic Development and Commercialization Agreement
28. November 2022 08:00 ET
|
iCAD, Inc.
Google Health AI and Cloud technology to be integrated into iCAD’s portfolio with potential to elevate performance and expand access to millions of women worldwide Agreement marks Google Health’s...
Positive New Research Presented at RSNA 2022 Reaffirms iCAD’s Breast AI Suite Improves Radiologists’ Performance and Breast Cancer Detection
21. November 2022 08:00 ET
|
iCAD, Inc.
Study affirms utility of ProFound AI’s Case Scores in improving cancer detection Company’s Breast AI Suite of deep-learning breast cancer detection, density assessment and risk evaluation tools...
iCAD to Participate in the 13th Annual Craig-Hallum Alpha Select Conference
15. November 2022 16:13 ET
|
iCAD, Inc.
NASHUA, N.H., Nov. 15, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Stacey...
iCAD to Present at HLTH 2022 With Google
14. November 2022 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., Nov. 14, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced iCAD will...
iCAD Reports Financial Results for Third Quarter Ended September 30, 2022
10. November 2022 16:03 ET
|
iCAD, Inc.
Company implements corporate strategic realignment Partnership-based recurring revenue model anticipated to drive future growth Cost structure reduction to decrease expenses by over $3 million...
iCAD to Join Forces with Radiology Partners, the Nation’s Largest Radiology Practice
10. November 2022 16:01 ET
|
iCAD, Inc.
NASHUA, N.H., Nov. 10, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the first...
iCAD to Report Third Quarter 2022 Financial Results on November 10, 2022
27. Oktober 2022 08:40 ET
|
iCAD, Inc.
NASHUA, N.H., Oct. 27, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...
iCAD and Solis Mammography Ink Deal to Collaborate on Use of AI to Evaluate Risk of Cardiovascular Disease
11. Oktober 2022 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., Oct. 11, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced a new...
iCAD To Participate in The Lake Street Capital Markets 6th Annual Best Ideas Growth (BIG6) Conference on September 14, 2022
07. September 2022 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., Sept. 07, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the...
iCAD Customers in the U.S. and Europe Increasingly Adopting Company’s Full Suite of Breast AI Technologies via Subscription Model
29. August 2022 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., Aug. 29, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that a...